RAYDERM HYDRATING TONER- glycerin toner liquid

Rayderm Hydrating Toner by

Drug Labeling and Warnings

Rayderm Hydrating Toner by is a Otc medication manufactured, distributed, or labeled by VORY MEDICAL. Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Glycerin (2.5%) - Skin Protectact

INACTIVE INGREDIENT

Purified Water, Propanediol, Dipropylene, Methyl Gluceth-20, Glycereth-26, Glycerin, Pentylene Glycol, Betaine, C12-14 Pareth-12, Trehalose, Salvia Hispanica Seed Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Polyquaternium-51, Sodium Citrate, Sea Buckthorn Water, Butylene Glycol, Ethylhexylglycerin, 1,2-Hexanediol, Citric Acid, Sodium Palmitoyl Proline, Nymphaea Tetragona Flower Extract, Green tea Extract, Black Rice Bran Extract, Cucumber Extract, Caprylyl Glycol, Fragrance

PURPOSE

Skin Protectact

WARNINGS

Precautions of Use
1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
2) Refrain from using on wound sites.
3) Storage and handling precautions:
i) Keep out of reach of children.
ii) Keep away from direct sunlight

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

Apply the toner on the skin and spread evenly.

DOSAGE & ADMINISTRATION

Apply the toner on the skin and spread evenly.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

RAYDERM HYDRATING TONER 
glycerin toner liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72543-004
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)	glycerin	6.25 g  in 250 mL

Inactive Ingredients
Ingredient Name	Strength
water (UNII: 059QF0KO0R)
PROPANEDIOL (UNII: 5965N8W85T)
DIPROPYLENE GLYCOL (UNII: E107L85C40)
METHYL GLUCETH-20 (UNII: J3QD0LD11P)
GLYCERETH-26 (UNII: NNE56F2N14)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
BETAINE (UNII: 3SCV180C9W)
C12-14 PARETH-12 (UNII: M0LJS773XW)
TREHALOSE (UNII: B8WCK70T7I)
SALVIA HISPANICA SEED (UNII: NU0OLX06F8)
CENTELLA ASIATICA (UNII: 7M867G6T1U)
POLYQUATERNIUM-51 (2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE/N-BUTYL METHACRYLATE; 3:7) (UNII: EL9825H96J)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO)
NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72543-004-01	250 mL in 1 PACKAGE; Type 0: Not a Combination Product	10/11/2018

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		10/11/2018

Labeler - VORY MEDICAL. Inc (694721104)

Registrant - VORY MEDICAL. Inc (694721104)

Establishment
Name	Address	ID/FEI	Business Operations
VORY MEDICAL. Inc		694721104	manufacture(72543-004)